Quotes Charles River Laboratories International, Inc. Deutsche Boerse AG
Stocks
RV6
US1598641074
Biotechnology & Medical Research
|
Real-time Estimate
Tradegate
01:23:34 18/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 247.75 EUR | +4.32% |
|
-0.13% | +38.84% |
Stock exchange
Deutsche Boerse AG
RV6 238.60 €
+0.46%
0
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| CRL | 285.07USD | +4.26% | 109M $ | ||
CBOE
| CRL | 284.43USD | +3.92% | 5.59M $ | |
Tradegate
| RV6 | 239.00EUR | +0.25% | 73.37K € | |
Mexican S.E.
| CRL * | 4,720.00MXN | -1.97% | 61.36K $ | |
Boerse Muenchen
| RV6 | 247.55EUR | +3.99% | 1.49K € | |
Deutsche Boerse AG
| RV6 | 238.60EUR | +0.46% | 0 € | |
Börse Stuttgart
| RV6 | 247.90EUR | +4.16% | 0 € | |
Berne S.E.
| RV6 | 226.97CHF | +2.07% | 0 CHF |
Quotes 5-day view: Charles River Laboratories International, Inc.
Delayed Quote Deutsche Boerse AG| 11/09/2026 | 14/09/2026 | 15/09/2026 | 16/09/2026 | 18/09/2026 | |
|---|---|---|---|---|---|
| Last | €235.20 | €240.80 | €235.50 | €237.50 | €238.60 |
| Volume | 0 | 48 | 0 | 22 | 0 |
| Change | -1.55% | +2.38% | -2.20% | +0.85% | +4.32% |
| Opening | €235.20 | €240.00 | €235.50 | €235.90 | €238.60 |
| High | €235.20 | €240.80 | €235.50 | €237.50 | €238.60 |
| Low | €235.20 | €240.00 | €235.50 | €235.90 | €238.60 |
Performance
| 1 day | +4.29% | ||
| 1 week | -0.13% | ||
| Current month | -4.75% | ||
| 1 month | -0.95% | ||
| 3 months | +50.06% | ||
| 6 months | +81.72% | ||
| Current year | +38.84% | ||
| 1 year | +87.28% | ||
| 3 years | +23.28% | ||
| 5 years | -35.86% | ||
| 10 years | +229.41% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (EUR)
13,052,284,993
Market Cap (USD)
13,052,284,993
Net sales (USD)
4,015,382,000
Number of employees
19,000
Sales / Employee (USD)
211,336
Free-Float
95.58%
Free-Float capitalization (EUR)
14,870,367,789
Free-Float capitalization (USD)
12,952,090,344
Average Daily Capital Traded
-.--%
Indicators
Moving average 5 days
237.58
Moving average 20 days
246.87
Moving average 50 days
225.62
Moving average 100 days
192.62
Price spread / (MMA5)
-4.10%
Price spread / (MMA20)
-0.36%
Price spread / (MMA50)
-8.93%
Price spread / (MMA100)
-22.25%
RSI 9 days
38.68
RSI 14 days
46.7
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.32% | -0.13% | +87.28% | +23.28% | 13.05B | ||
| +1.23% | +1.87% | -0.15% | +28.45% | 45.91B | ||
| +0.40% | +5.56% | +45.49% | +29.74% | 44.25B | ||
| +0.47% | -3.16% | +349.48% | +536.65% | 41.99B | ||
| +1.19% | +3.21% | +6.19% | +68.87% | 39.58B | ||
| +1.75% | -1.53% | +12.22% | +41.11% | 31.08B | ||
| +0.48% | +6.45% | +24.70% | +127.31% | 17.21B | ||
| -3.23% | -8.49% | - | - | 16.27B | ||
| +2.92% | +8.40% | +22.46% | +39.73% | 14.96B | ||
| -1.03% | +4.11% | -1.55% | -34.42% | 13.42B | ||
| Average | +0.85% | +1.54% | +60.68% | +95.63% | 27.77B | |
| Weighted average by Cap. | +0.86% | +0.68% | +73.38% | +121.58% |
Historical Quotes: Charles River Laboratories International, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 1 week | 235.2 | 240.8 | |
| 1 month | 235.2 | 255.7 | |
| Current year | 127.95 | 255.7 | |
| 1 year | 124.25 | 255.7 | |
| 3 years | 87.7 | 255.7 | |
| 5 years | 87.7 | 388 | |
| 10 years | 59.83 | 388 |
Monthly variations
Annual variations
| 2026 | +38.20% | ||
| 2025 | -3.32% | ||
| 2024 | -16.98% | ||
| 2023 | +3.16% | ||
| 2022 | -36.72% | ||
| 2021 | +62.38% | ||
| 2020 | +47.45% | ||
| 2019 | +44.38% | ||
| 2018 | +4.91% | ||
| 2017 | +26.84% | ||
| 2016 | -1.68% | ||
| 2015 | +38.94% | ||
| 2014 | +36.70% | ||
| 2013 | +38.74% | ||
| 2012 | +33.11% | ||
| 2011 | -22.60% | ||
| 2010 | +16.20% | ||
| 2009 | +29.89% | ||
| 2008 | -60.35% | ||
| 2007 | +37.10% | ||
| 2006 | -8.80% | ||
| 2005 | +6.03% | ||
| 2004 | +22.44% | ||
| 2003 | -24.97% | ||
| 2002 | -3.81% | ||
| 2001 | +30.48% | ||
| 2000 | +8.35% |
- Stock Market
- Stocks
- CRL Stock
- RV6 Stock
- Quotes Charles River Laboratories International, Inc.
Select your edition
All financial news and data tailored to specific country editions

















